Author:
Riley Thomas V.,Kimura Tomomi
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical)
Reference69 articles.
1. Chakra CNA, Pepin J, Sirard S, Valiquette L. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS ONE. 2014;9:e107420.
2. Rupnik M, Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol. 2009;7:526–36.
3. Collins DA, Hawkey PM, Riley TV. Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control [Internet]. 2013;2:21. http://aricjournal.biomedcentral.com/articles/10.1186/2047-2994-2-21 .
4. Yamagishi Y, Mikamo H. Recent epidemiology of Clostridium difficile infection in Japan. Jpn J Antibiot. 2015;68:345–58.
5. Shionogi & Co. Antitrichomonal agent, Flagyl®—approval for additional indication for amoebic dysentery, giardiasis, anaerobic infection and infectious enteritis [Internet]. 2012 [cited 2017 Jun 7]. http://www.shionogi.co.jp/en/company/news/2012/pmrltj0000000wim-att/e_120810-2.pdf .
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献